File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines

TitleESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines
Authors
Issue Date25-Apr-2024
PublisherSpringer
Citation
European Child & Adolescent Psychiatry, 2024, v. 33, n. 5, p. 1605-1608 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/346220
ISSN
2023 Impact Factor: 6.0
2023 SCImago Journal Rankings: 2.175

 

DC FieldValueLanguage
dc.contributor.authorCortese, Samuele-
dc.contributor.authorCoghill, David-
dc.contributor.authorFegert, Joerg M-
dc.contributor.authorMattingly, Gregory W-
dc.contributor.authorRohde, Luis A-
dc.contributor.authorWong, Ian CK-
dc.contributor.authorFaraone, Stephen V-
dc.date.accessioned2024-09-12T00:30:55Z-
dc.date.available2024-09-12T00:30:55Z-
dc.date.issued2024-04-25-
dc.identifier.citationEuropean Child & Adolescent Psychiatry, 2024, v. 33, n. 5, p. 1605-1608-
dc.identifier.issn1018-8827-
dc.identifier.urihttp://hdl.handle.net/10722/346220-
dc.languageeng-
dc.publisherSpringer-
dc.relation.ispartofEuropean Child & Adolescent Psychiatry-
dc.titleESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines-
dc.typeArticle-
dc.identifier.doi10.1007/s00787-024-02443-5-
dc.identifier.pmid38662057-
dc.identifier.scopuseid_2-s2.0-85191323267-
dc.identifier.volume33-
dc.identifier.issue5-
dc.identifier.spage1605-
dc.identifier.epage1608-
dc.identifier.eissn1435-165X-
dc.identifier.issnl1018-8827-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats